期刊： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023; 32 (7)
Purpose: This study aimed to investigate co-prescribing of contraindicated drugs with fluconazole and itraconazole using real-world nationwide data.Me......
期刊： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023; 32 (10)
Purpose: The risk minimization measures (RMM) for systemic use of thiocolchicoside (TCC) was implemented across Europe during 2014-2016. RMM included ......
期刊： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023; 32 (10)
Background: Real-world data (RWD) are increasingly used to generate real-world evidence (RWE) of vaccine safety and effectiveness for regulatory purpo......
期刊： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023; 32 (12)
Purpose: This regulatory post-marketing surveillance (PMS) was organized to identify the safety and effectiveness of ambrisentan in the Korean populat......
期刊： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023; ()
Background: Adverse drug reactions (ADRs) are common and a leading cause of injury. However, information on ADR risks of individual medicines is often......
